当前位置: X-MOL 学术Cancer Biother. Radiopharm. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
[99mTc]-Bis-Methionine-DTPA Single-Photon Emission Computed Tomography Impacting Glioma Management: A Sensitive Indicator for Postsurgical/Chemoradiotherapy Response Assessment
Cancer Biotherapy and Radiopharmaceuticals ( IF 2.4 ) Pub Date : 2021-09-06 , DOI: 10.1089/cbr.2020.3696
Nisha Rani 1 , Baljinder Singh 1 , Narendra Kumar 2 , Paramjeet Singh 3 , Puja P Hazari 4 , Sameer Vyas 3 , Monika Hooda 1 , Ajay Chitkara 1 , Amit Singh Shekhawat 1 , Sunil K Gupta 5 , Bishan D Radotra 6 , Anil K Mishra 4
Affiliation  

Background: The present study evaluated the prognostic value of [99mTc]MDM (bis-methionine-DTPA) follow-up single-photon emission computed tomography (SPECT) imaging for response assessment to chemoradiotherapy in glioma postoperatively.

中文翻译:

[99mTc]-Bis-蛋氨酸-DTPA 单光子发射计算机断层扫描影响胶质瘤管理:术后/放化疗反应评估的敏感指标

背景:本研究评估了 [ 99m Tc]MDM(双蛋氨酸-DTPA)随访单光子发射计算机断层扫描(SPECT)成像对胶质瘤术后放化疗反应的预后价值。
更新日期:2021-09-09
down
wechat
bug